Inogen to Announce Third Quarter 2020 Financial Results on Wednesday, November 4th, 2020
Inogen, a medical technology company specializing in respiratory products, will announce its third quarter 2020 financial results on November 4, 2020, after market close. The company will host a conference call at 1:30 PM PT/4:30 PM ET for investors and analysts to discuss the results. Interested participants can join by calling the provided numbers or by accessing the live webcast through Inogen's Investor Relations website. A replay of the call will be available until November 18, 2020. For more information, visit the Inogen website.
- None.
- None.
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2020 financial results after market close on Wednesday, November 4th, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.
A replay of the call will be available beginning, November 4th, 2020 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on November 18th, 2020. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Access Code: 13672721. The webcast will also be available on Inogen's website for one year following the completion of the call.
Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.
About Inogen
We are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
